MCLR Stock Overview
Medclair AB, a research and development company, specializes in the measurement, collection, and destruction of nitrous oxide (N2O).
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Medclair AB Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr1.15 |
| 52 Week High | kr0 |
| 52 Week Low | kr0 |
| Beta | 0.40 |
| 1 Month Change | -8.73% |
| 3 Month Change | -22.30% |
| 1 Year Change | -25.23% |
| 3 Year Change | -59.15% |
| 5 Year Change | n/a |
| Change since IPO | -32.35% |
Recent News & Updates
Recent updates
Shareholder Returns
| MCLR | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -4.2% | 1.1% | 2.8% |
| 1Y | -25.2% | -5.1% | 13.6% |
Return vs Industry: MCLR underperformed the Swedish Medical Equipment industry which returned -3.6% over the past year.
Return vs Market: MCLR underperformed the Swedish Market which returned 14.7% over the past year.
Price Volatility
| MCLR volatility | |
|---|---|
| MCLR Average Weekly Movement | 4.9% |
| Medical Equipment Industry Average Movement | 7.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in SE Market | 12.8% |
| 10% least volatile stocks in SE Market | 3.6% |
Stable Share Price: MCLR's share price has been volatile over the past 3 months.
Volatility Over Time: MCLR's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 12 | Mikael Konig | www.medclair.com |
Medclair AB, a research and development company, specializes in the measurement, collection, and destruction of nitrous oxide (N2O). It offers mobile destruction unit, a solution that can be moved anywhere, where N2O is needed for pain relief; central destruction unit, a system designed for larger N2O destruction volumes; exhalation device that addresses the problem with residual levels of N2O in the patient’s exhalation; collection units for non-frequent use of N2O, and less frequent use or fitting in emergency services vehicles; and Nitrous Oxide Detector, an N2O measuring device for detecting the levels of N2O in the air. The company serves maternity wards, children’s healthcare, and dental care facilities.
Medclair AB Fundamentals Summary
| MCLR fundamental statistics | |
|---|---|
| Market cap | kr94.87m |
| Earnings (TTM) | kr272.00k |
| Revenue (TTM) | kr40.95m |
348.8x
P/E Ratio2.3x
P/S RatioIs MCLR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MCLR income statement (TTM) | |
|---|---|
| Revenue | kr40.95m |
| Cost of Revenue | kr14.37m |
| Gross Profit | kr26.58m |
| Other Expenses | kr26.31m |
| Earnings | kr272.00k |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0033 |
| Gross Margin | 64.91% |
| Net Profit Margin | 0.66% |
| Debt/Equity Ratio | 1.0% |
How did MCLR perform over the long term?
See historical performance and comparison